跳到主要內容

Leiden Jeffrey M 的 Form 4 申報

Vertex Pharmaceuticals Inc(VRTX),2025/12/5 申報

申報編號
0000875320-25-000242
申報時間
2025/12/5
交易日
2025/12/3-12/4
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 14 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $2,865 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Leiden Jeffrey MCIK 0001242825董事、高階主管(執行董事長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2025/12/3Common StockM行使選擇權取得+63,781$86.52+$5,518,332.1287,807直接
2025/12/3Common StockS賣出處分−4,469$440.40F2,F3−$1,968,147.683,338直接
2025/12/3Common StockS賣出處分−1,320$441.26F2,F4−$582,463.282,018直接
2025/12/3Common StockS賣出處分−2,469$443.21F2,F5−$1,094,285.4979,549直接
2025/12/3Common StockS賣出處分−4,352$444.36F2,F6−$1,933,854.7275,197直接
2025/12/3Common StockS賣出處分−7,899$445.56F2,F7−$3,519,478.4467,298直接
2025/12/3Common StockS賣出處分−1,152$447.05F2,F8−$515,001.666,146直接
2025/12/3Common StockS賣出處分−2,320$448.78F2,F9−$1,041,169.663,826直接
2025/12/3Common StockS賣出處分−5,880$449.84F2,F10−$2,645,059.257,946直接
2025/12/3Common StockS賣出處分−5,809$451.20F2,F11−$2,621,020.852,137直接
2025/12/3Common StockS賣出處分−15,681$452.20F2,F12−$7,090,948.236,456直接
2025/12/3Common StockS賣出處分−10,360$453.34F2,F13−$4,696,602.426,096直接
2025/12/3Common StockS賣出處分−2,070$455.22F2,F14−$942,305.424,026直接
2025/12/4Common StockM行使選擇權取得+1$91.05+$91.0524,027直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2025/12/3Common StockM行使選擇權處分−63,781$0.00$00直接
2025/12/4Common StockM行使選擇權處分−1$0.00$00直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

表 I 有 12 筆交易的價格引用這則附註。

F3

Open market sales reported on this line occurred at a weighted average price of $440.40 (range $440.04 to $441.00).

表 I 有 1 筆交易的價格引用這則附註。

F4

Open market sales reported on this line occurred at a weighted average price of $441.26 (range $441.14 to $442.00).

表 I 有 1 筆交易的價格引用這則附註。

F5

Open market sales reported on this line occurred at a weighted average price of $443.21 (range $442.94 to $443.93).

表 I 有 1 筆交易的價格引用這則附註。

F6

Open market sales reported on this line occurred at a weighted average price of $444.36 (range $444.00 to $444.94).

表 I 有 1 筆交易的價格引用這則附註。

F7

Open market sales reported on this line occurred at a weighted average price of $445.56 (range $445.00 to $445.82).

表 I 有 1 筆交易的價格引用這則附註。

F8

Open market sales reported on this line occurred at a weighted average price of $447.05 (range $447.00 to $447.23).

表 I 有 1 筆交易的價格引用這則附註。

F9

Open market sales reported on this line occurred at a weighted average price of $448.78 (range $448.18 to $449.12).

表 I 有 1 筆交易的價格引用這則附註。

F10

Open market sales reported on this line occurred at a weighted average price of $449.84 (range $449.22 to $450.18).

表 I 有 1 筆交易的價格引用這則附註。

F11

Open market sales reported on this line occurred at a weighted average price of $451.20 (range $450.71 to $451.70).

表 I 有 1 筆交易的價格引用這則附註。

F12

Open market sales reported on this line occurred at a weighted average price of $452.20 (range $451.73 to $452.69).

表 I 有 1 筆交易的價格引用這則附註。

F13

Open market sales reported on this line occurred at a weighted average price of $453.34 (range $452.91 to $453.70).

表 I 有 1 筆交易的價格引用這則附註。

F14

Open market sales reported on this line occurred at a weighted average price of $455.22 (range $454.88 to $455.66).

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)